Currently, Alison serves as the Chair of Dechra Pharmaceuticals plc (Dechra), a specialist veterinary products business undergoing acquisition by EQT. She also holds the position of Non-Executive Director at Tesco plc and serves as the Chair of general insurer Ageas UK. Alison is expected to join HL's Board in early 2024. Alison previously served as…
Read more
Chris Hill, Chief Executive Officer, commented: We delivered net new business of £1.7 billion in the period, up 6% on the previous quarter. The tax year end season remains a critical time for our clients and this year we focused on supporting them to navigate the changes to the tax landscape, making the most of…
Read more
Despite the decline in some metrics, Hargreaves Lansdown's pre-tax profit rose 31% to £197.6 million from £151.2 million, while underlying pre-tax profit, which excludes the strategic investment costs for the period, increased 30% to £211.9 million from £163.5 million. As a result, earnings per share were 33.1p, 29% above the previous year's period of 25.7p.…
Read more
Olly has served as pendent non-executive director at Hargreaves Lansdown (HL) since June 2019. Prior to becoming CEO of Dunnhumby, he worked at analytics company RELX for 17 years. While there, he held a number of senior digital roles and helped drive its digital transformation. Chair Deanna Oppenheimer said: Having worked with Dan in a…
Read more
A financial industry veteran, Hill spent thirty years in different companies in executive roles. Prior to Hargreaves Lansdown, he served as CFO at IG Group and he has also worked at Travelex as Group Financial Controller and as CFO. Hill commented: I have been privileged to lead the Company over the last six years through…
Read more